Skip to main content

Intracerebral hemorrhage due to moyamoya syndrome as a rare presentation of cerebral rheumatoid vasculitis: a case report

Abstract

Background

Central nervous system affection in rheumatoid arthritis is rare. The most frequently encountered neurological complications with rheumatoid arthritis are peripheral neuropathy and atlantoaxial subluxation with subsequent spinal cord compression. Cerebral rheumatoid vasculitis is not a common complication.

Case presentation

A 60-year-old Egyptian female with history of rheumatoid arthritis for 15 years presented with headache and receptive aphasia. Computed tomography scan of the brain showed recent intracerebral hemorrhage. Digital subtraction cerebral angiography showed moyamoya syndrome angiographic pattern as sequelae of intracranial vasculitis. The patient did well with conservative management.

Conclusion

Cerebral rheumatoid vasculitis is rare, but can be a life-threatening condition. Early management of rheumatoid arthritis is essential to prevent such serious complication.

Background

Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease which primarily affects the small joints of the hands and feet. Rheumatoid vasculitis (RV) typically happens with long-standing RA or with high levels of rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) [1]. RV occurs due to immune-complex deposition within the sub-endothelium of affected vessels, a mechanism that will be increased in patients with high levels of RF and anti-CCP [2]. However, central nervous system vasculitis in RA is sort of rare and the literature contains solely few case reports on intracranial arteritis presenting as intracerebral hemorrhage (ICH). [3].

Case presentation

A 60-year-old Egyptian female with irrelevant family history, past history of RA of 15 years duration, mainly in the form of small joint arthritis, otherwise no relevant past history, presented to the emergency room with sudden onset of persistent headache, inability to understand speech with in appropriate response and poor communication with her family. On examination, her vital signs were within the normal range. Neurological evaluation revealed that the patient suffers from receptive aphasia which is the cause of her symptoms. The rest of the neurological examination was normal. Computed tomography (CT) of the brain (General Electric, United States) showed left temporoparietal hematoma as shown in Fig. 1. Fundus examination showed no papilledema.

Fig. 1
figure1

AD Computed tomography scan of the brain showing left temporoparietal hemorrhage

After discussion with the attending neurosurgeon, the patient was candidate for conservative management. She was admitted to the intensive care unit (ICU). The patient received intravenous mannitol 20% (100 ml/6 h. for 5 days) as a brain dehydrating measure and neuroprotective therapy. Serial CT brain showed stationary size of the hemorrhage. After 48 h of ICU monitoring, the patient was stable and no further neurological deficit developed, so she was transferred to the medical ward.

Due to the unusual location of the intracranial hematoma, digital subtraction angiography (DSA) was requested. The procedure was done using a monoplane neurovascular machine (Siemens, Germany). DSA revealed occlusion of the distal parts of both internal carotid arteries with filling of both middle cerebral arteries through a newly formed network of blood vessels; neo-angiogenesis. This picture is characteristic of moyamoya syndrome secondary to intracranial vasculitis. The angiography findings are shown in Fig. 2.

Fig. 2
figure2

A Left internal carotid artery (ICA) angiogram anterior view showing occlusion of its distal part of with neo-angiogenesis. B Left ICA angiogram lateral view. C Right ICA angiogram anterior view showing occlusion of its distal part with neo-angiogenesis. D Right ICA angiogram lateral view

Laboratory investigations revealed normal rheumatoid factor (12 IU/ml), normal anti-CCP antibodies (4.3 unit/ml), elevated C-reactive protein (14 mg/L), elevated erythrocyte sedimentation rate (81 mm/h), normal hemoglobin level (12.9 gm/dL), normal white blood cells count (6120/mm3), normal platelets count (280,000/mm3), normal prothrombin time (10.5 s) and normal partial thromboplastin time (32.4 s). A transthoracic echocardiogram was unremarkable.

The diagnosis of RA was made several years ago and the patient was on oral prednisolone 5 mg per day and leflunomide 20 mg per day but she was non-compliant. Rheumatologic consultation was done and hydroxychloroquine 400 mg per day was added to her treatment. The patient was discharged after 1 week of hospital admission with disappearance of the headache and partial recovery of her aphasia symptoms as she could understand simple commands with appropriate response.

Discussion

Collagen diseases are often complicated by cerebrovascular disorders; however, these rarely occur in RA [4]. The rate of occurrence of cerebral vasculitis in patients with RA is 1–8% [5].

The most frequent neurological complications with RA are atlantoaxial subluxation, polymyositis, mononeuritis multiplex, peripheral neuropathy, rheumatoid nodules within the central or peripheral nervous system, and RV [6].They were initially described in seropositive patients with long history of active disease, with subcutaneous nodules and extra-articular manifestations [7].

Our case was seronegative and had a long history of active RA, but no previous extra-articular manifestations.

The neurological manifestations of cerebral RV include hemiparesis, focal onset epilepsy, cranial nerve palsy, visual field impairment, altered consciousness, and cognitive impairment [8, 9].

The neurological manifestations in our case were headache and receptive aphasia due to the occurrence of intracerebral hemorrhage in absence of other risk factors for hemorrhage.

Two previous studies evaluated various autoimmune diseases and the risk of ICH. Both studies found that the danger of ICH is higher in patients with RA, with the highest risk occurring during the first year of diagnosis [10]. In a meta-analysis of 23 studies, it was found that patients with RA have a risk of hemorrhagic stroke 1.68 times higher than that in normal individuals [11].

Moyamoya disease is a rare neurovascular disorder of unknown etiology characterized by progressive stenosis or occlusion of the supraclinoid portion of both internal carotid arteries and development of collateral vessels. The classical presentations of the disease in children are transient ischemic attacks and seizures, whereas in adults, cerebral ischemia and cerebral hemorrhage are the commonest manifestations [12].

Moyamoya syndrome or secondary moyamoya disease has similar angiographic findings as primary moyamoya disease. Moyamoya syndrome can be seen in patients with cerebral vasculitis, fibromuscular dysplasia, sickle cell disease, and advanced intracranial atherosclerosis. The incidence of moyamoya syndrome in patients with RA is unclear due to lack of sufficient data [13].

Our case showed moyamoya syndrome angiographic pattern with DSA, denting chronic intracranial vasculitis. Also, intracerebral hemorrhage was the presenting manifestation as reported in the literature.

Conclusions

Central nervous system involvement in rheumatic arthritis may be associated with high morbidity and can be a life-threatening condition. In rheumatoid disease, early diagnosis, proper treatment, good adherence to treatment plan and regular follow-up visits are essential in preventing serious complications.

Availability of data and materials

The corresponding author takes full responsibility for the data, has full access to all of the data, and has the right to publish any and all data separate and apart from any sponsor.

Abbreviations

Anti-CCP:

Anti-cyclic citrullinated peptide

CT brain:

Computed tomography of the brain

DSA:

Digital subtraction angiography

ICH:

Intracerebral hemorrhage

ICU:

Intensive care unit

RA:

Rheumatoid arthritis

RV:

Rheumatoid vasculitis

References

  1. 1.

    Del Rincón I, Williams K, Stern MP, Freeman GL, O’Leary DH, et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum. 2003;48(7):1833–40.

    Article  Google Scholar 

  2. 2.

    Zöller B, Li X, Sundquist J, Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012;12:41.

    Article  Google Scholar 

  3. 3.

    Kousa O, Awad DH, Hydoub YM, Awawdeh R, Andukuriet V. Intracerebral hemorrhage in a patient with untreated rheumatoid arthritis: case report and literature review. Cureus. 2019;11(7):e5175.

    PubMed  PubMed Central  Google Scholar 

  4. 4.

    Ando Y, Kai S, Uyama E, Lyonaga K, Hashimoto Y, et al. Involvement of the central nervous system in rheumatoid arthritis: its clinical manifestations and analysis by magnetic resonance imaging. Intern Med. 1995;34(3):188–91.

    CAS  Article  Google Scholar 

  5. 5.

    Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct? Rheumatology (Oxford). 2004;43(7):920–3.

    CAS  Article  Google Scholar 

  6. 6.

    Sofat N, Malik O, Higgens CS. Neurological involvement in patients with rheumatic disease. QJM. 2006;99(2):69–79.

    CAS  Article  Google Scholar 

  7. 7.

    Pons NC, Montalà N, Valverde J, Brell M, Ferrer I, et al. Isolated cerebral vasculitis associated with rheumatoid arthritis. Jt Bone Spine. 2010;77(4):361–3.

    Article  Google Scholar 

  8. 8.

    Mrabet D, Meddeb N, Ajlani H, Sahli H, Sellami S. Cerebral vasculitis in a patient with rheumatoid arthritis. Jt Bone Spine. 2007;74(2):201–4.

    Article  Google Scholar 

  9. 9.

    Akrout R, Bendjemaa S, Fourati H, Ezzeddine M, Hachicha I, et al. Cerebral rheumatoid vasculitis: a case report. J Med Case Rep. 2012;6:302.

    Article  Google Scholar 

  10. 10.

    Ramagopalan SV, Pakpoor J, Seminog O, Goldacre R, Graham L, et al. Risk of subarachnoid haemorrhage in people admitted to hospital with selected immune-mediated diseases: record-linkage studies. BMC Neurol. 2013;13:176.

    Article  Google Scholar 

  11. 11.

    Wiseman SJ, Ralston SH, Wardlaw JM. Cerebrovascular disease in rheumatic diseases: a systematic review and meta-analysis. Stroke. 2016;47(4):943–50.

    Article  Google Scholar 

  12. 12.

    Suzuki J, Takaku A. Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–99.

    CAS  Article  Google Scholar 

  13. 13.

    Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

No funds were received to fulfill this work.

Author information

Affiliations

Authors

Contributions

AH: design and conceptualized the study. AE, SS, AS: conception of the work and drafting the manuscript. SH, RY, MH: acquisition and analysis of data. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Ayman Hassan El-Sudany.

Ethics declarations

Ethics approval and consent to participate

All procedures performed in the study were in accordance with the ethical standards of the Faculty of Medicine, Ain Shams University Research and Ethical Committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. We obtained approval from the research ethics committee on February 2021.

Consent for publication

Written informed consent was obtained from the participant for publication of this case and accompanying images.

Competing interests

The authors declare that they do not have any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

El-Sudany, A.H., El-Halawany, S.H., Georgy, S.S. et al. Intracerebral hemorrhage due to moyamoya syndrome as a rare presentation of cerebral rheumatoid vasculitis: a case report. Egypt J Neurol Psychiatry Neurosurg 57, 138 (2021). https://doi.org/10.1186/s41983-021-00392-3

Download citation

Keywords

  • Rheumatoid arthritis
  • Cerebral rheumatoid vasculitis
  • Intracerebral hemorrhage
  • Moyamoya syndrome
  • Digital subtraction angiography